Comparison of Primary Orchiectomy with Oestrogen Therapy in Advanced Prostatic Cancer; A 2‐Year Follow‐up Report of a National, Prospective Prostatic Cancer Study
Authors:
- 1 October 1986
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 58 (5) , 528-533
Abstract
Summary— Two hundred and seventy‐seven patients with advanced prostatic cancer were treated by either orchiectomy or oestrogen. During the 2‐year follow‐up period, the response to treatment was considered more favourable in the oestrogen group, and this response was particularly emphasised in patients with poorly differentiated tumour and metastases at the time of diagnosis. Further evaluations included the cardiovascular side effects of oestrogen therapy.Keywords
This publication has 10 references indexed in Scilit:
- Androgen Receptor Assays in Advanced Prostatic CancerUrologic Clinics of North America, 1984
- Management of Newly Diagnosed Metastatic Carcinoma of the ProstateUrologic Clinics of North America, 1984
- Correlation of Prostatic Nuclear Androgen Receptor Content with Duration of Response and Survival Following Hormonal Therapy in Advanced Prostatic CancerJournal of Urology, 1982
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- Hormonal Therapy of Prostatic CancerCancer, 1980
- Hormone ReceptorsNew England Journal of Medicine, 1979
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Carcinoma of the Prostate: A RevivewJournal of Urology, 1978
- Treatment of Prostatic Carcinoma with Polyestradiol Phosphate Combined with EthinylestradiolScandinavian Journal of Urology and Nephrology, 1971
- ENDOCRINE CONTROL OF PROSTATIC CARCINOMAJAMA, 1950